AFFW News 6.0000 Affinity Mediaworks Corp. (AFFW)
Post# of 273330
Posted On: 04/17/2014 7:49:14 AM
Affinity Mediaworks Corp. (AFFW) 6.0000 $AFFW
Fortitude Group, Inc. Submits Special Share Issuance Certificate to Transfer Agent
Marketwire - Thu Apr 10, 8:03AM CDT
Fortitude Group, Inc. (OTC: FRTD) announced today that on April 5, 2014, the company received 9,250,000 shares of Affinity Mediaworks Corp. (OTCQB: AFFW) and has submitted the certificate to the Affinity transfer agent to have the shares re-issued and forwarded to bona fide Fortitude shareholders of record, as of the calendar date: March 14, 2014 at 6:00pm EDT.
Fortitude Group, Inc. Launches 420cashcard.com
Marketwire - Mon Mar 24, 8:45AM CDT
Fortitude Group, Inc. (OTC: FRTD) announced today their successful launch of 420cashcard.com.
Affinity Medical Corp. Strongly Positioned to Address Demand for Home-Based Treatment Program for Cancer Therapies
ACCESSWIRE - Thu Sep 12, 11:01AM CDT
NEW BRUNSWICK, Canada, September 12, 2013 - (ACCESSWIRE) - Affinity Medical Corp. (OTCQB: AFFW); a company focused on creating a network of physicians and treatment centers that offer patients homeopathic, alternative treatments which is an alternative solution to combat cancer, diabetes, rheumatoid arthritis, and many other illnesses; announced today its home-based treatment program to combat cancer, as home-based treatments continue to gain in popularity and attract the attention of patients worldwide. The announcement was made by Mr. Timo Strattner, CEO of Affinity Medical Corp.
Affinity Medical Corp. Announces Immediate Operational Capabilities to Serve Patients with Cancer, Diabetes, and Rheumatoid Arthritis via Its Clinical Network of More than 300 Physicians in Over 20 Countries
ACCESSWIRE - Thu Aug 29, 6:06AM CDT
New Brunswick, Canada (ACCESSWIRE - 8/29/2013 7:00:00 AM) - Affinity Medical Corp. (OTCQB: AFFW); a company focused on creating a network of treatment centers that offer patients homeopathic, alternative treatments of the BX Protocol (BX Antitoxin/Energy Catalyst), which is proven to be an alternative solution to combat cancer, diabetes, rheumatoid arthritis, and many other illnesses; announced today its immediate operational capabilities to provide treatment to patients with cancer, diabetes, rheumatoid arthritis, lyme disease, Parkinsons, and other illnesses via its clinical network of more than 300 physicians in over 20 countries. As such, Affinity Medical can immediately respond and offer treatments to a large number of patient's requests worldwide. The announcement was made by Mr. Timo Strattner, CEO of Affinity Medical Corp.
OTC Daily Alert Stock Watch - Affinity Mediaworks Corp. (OTCQB: AFFW)
WorldStockWire - Tue Aug 27, 4:15AM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Affinity Medical Pushes Forward with Promising Cancer Treatment
ACCESSWIRE - Mon Aug 26, 7:55AM CDT
Company Establishes Relationship with Renowned Delta Institute International
Fortitude Group, Inc. Submits Special Share Issuance Certificate to Transfer Agent
Marketwire - Thu Apr 10, 8:03AM CDT
Fortitude Group, Inc. (OTC: FRTD) announced today that on April 5, 2014, the company received 9,250,000 shares of Affinity Mediaworks Corp. (OTCQB: AFFW) and has submitted the certificate to the Affinity transfer agent to have the shares re-issued and forwarded to bona fide Fortitude shareholders of record, as of the calendar date: March 14, 2014 at 6:00pm EDT.
Fortitude Group, Inc. Launches 420cashcard.com
Marketwire - Mon Mar 24, 8:45AM CDT
Fortitude Group, Inc. (OTC: FRTD) announced today their successful launch of 420cashcard.com.
Affinity Medical Corp. Strongly Positioned to Address Demand for Home-Based Treatment Program for Cancer Therapies
ACCESSWIRE - Thu Sep 12, 11:01AM CDT
NEW BRUNSWICK, Canada, September 12, 2013 - (ACCESSWIRE) - Affinity Medical Corp. (OTCQB: AFFW); a company focused on creating a network of physicians and treatment centers that offer patients homeopathic, alternative treatments which is an alternative solution to combat cancer, diabetes, rheumatoid arthritis, and many other illnesses; announced today its home-based treatment program to combat cancer, as home-based treatments continue to gain in popularity and attract the attention of patients worldwide. The announcement was made by Mr. Timo Strattner, CEO of Affinity Medical Corp.
Affinity Medical Corp. Announces Immediate Operational Capabilities to Serve Patients with Cancer, Diabetes, and Rheumatoid Arthritis via Its Clinical Network of More than 300 Physicians in Over 20 Countries
ACCESSWIRE - Thu Aug 29, 6:06AM CDT
New Brunswick, Canada (ACCESSWIRE - 8/29/2013 7:00:00 AM) - Affinity Medical Corp. (OTCQB: AFFW); a company focused on creating a network of treatment centers that offer patients homeopathic, alternative treatments of the BX Protocol (BX Antitoxin/Energy Catalyst), which is proven to be an alternative solution to combat cancer, diabetes, rheumatoid arthritis, and many other illnesses; announced today its immediate operational capabilities to provide treatment to patients with cancer, diabetes, rheumatoid arthritis, lyme disease, Parkinsons, and other illnesses via its clinical network of more than 300 physicians in over 20 countries. As such, Affinity Medical can immediately respond and offer treatments to a large number of patient's requests worldwide. The announcement was made by Mr. Timo Strattner, CEO of Affinity Medical Corp.
OTC Daily Alert Stock Watch - Affinity Mediaworks Corp. (OTCQB: AFFW)
WorldStockWire - Tue Aug 27, 4:15AM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Affinity Medical Pushes Forward with Promising Cancer Treatment
ACCESSWIRE - Mon Aug 26, 7:55AM CDT
Company Establishes Relationship with Renowned Delta Institute International
(0)
(0)